We're thrilled to share that Trisafe Biotech has been awarded the 6th A*STAR–SIP Technology Support Grant, valued at 1 million RMB!
This achievement marks a major milestone in our journey to translate cutting-edge antimicrobial innovations into real-world healthcare applications. The grant will further boost our R&D collaborations and accelerate the development and commercialisation of our Polyionene-based antimicrobial technologies and products in the China market.
We extend our heartfelt appreciation to A*STAR and the Suzhou Industrial Park (SIP) for their continued trust and support in our vision to advance preventive healthcare through science and innovation.
Here's to the next chapter of collaboration, growth, and impact!
